Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon
出版年份 2018 全文链接
标题
Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 293, Issue 16, Pages 6187-6200
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2018-02-16
DOI
10.1074/jbc.m117.816868
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression
- (2017) Bing Zhou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells
- (2017) D T Saenz et al. LEUKEMIA
- New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation
- (2016) Xin Wang et al. BIOCHEMICAL PHARMACOLOGY
- The molecular mechanism of thalidomide analogs in hematologic malignancies
- (2016) Stefanie Lindner et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligase
- (2016) Georg Petzold et al. NATURE
- A calcium- and calpain-dependent pathway determines the response to lenalidomide in myelodysplastic syndromes
- (2016) Jing Fang et al. NATURE MEDICINE
- Immunomodulatory drugs disrupt the cereblon–CD147–MCT1 axis to exert antitumor activity and teratogenicity
- (2016) Ruth Eichner et al. NATURE MEDICINE
- PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
- (2016) Kanak Raina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibody therapy alone and in combination with targeted drugs in chronic lymphocytic leukemia
- (2016) Tadeusz Robak et al. SEMINARS IN ONCOLOGY
- Cereblon negatively regulates TLR4 signaling through the attenuation of ubiquitination of TRAF6
- (2016) Yoon Min et al. Cell Death & Disease
- Protein Degradation by In-Cell Self-Assembly of Proteolysis Targeting Chimeras
- (2016) Honorine Lebraud et al. ACS Central Science
- Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
- (2015) Michael Zengerle et al. ACS Chemical Biology
- BET bromodomain inhibition suppresses graft-versus-host disease after allogeneic bone marrow transplantation in mice
- (2015) Y. Sun et al. BLOOD
- CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL
- (2015) P. R. Hagner et al. BLOOD
- Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
- (2015) Jing Lu et al. CHEMISTRY & BIOLOGY
- Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
- (2015) Jan Krönke et al. NATURE
- Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors
- (2015) R Gopalakrishnan et al. ONCOGENE
- Phthalimide conjugation as a strategy for in vivo target protein degradation
- (2015) G. E. Winter et al. SCIENCE
- Rate of CRL4CRBN substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4
- (2015) C C Bjorklund et al. Blood Cancer Journal
- The IMiDs targets IKZF-1/3 and IRF4 as novel negative regulators of NK cell-activating ligands expression in multiple myeloma
- (2015) Cinzia Fionda et al. Oncotarget
- Lenalidomide enhances antitumor functions of chimeric antigen receptor modified T cells
- (2015) Pavel Otáhal et al. OncoImmunology
- Ikaros Imposes a Barrier to CD8+ T Cell Differentiation by Restricting Autocrine IL-2 Production
- (2014) S. O'Brien et al. JOURNAL OF IMMUNOLOGY
- Thalidomide mimics uridine binding to an aromatic cage in cereblon
- (2014) Marcus D. Hartmann et al. JOURNAL OF STRUCTURAL BIOLOGY
- Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomide
- (2014) Eric S. Fischer et al. NATURE
- Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogs
- (2014) Philip P Chamberlain et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Measuring cereblon as a biomarker of response or resistance to lenalidomide and pomalidomide requires use of standardized reagents and understanding of gene complexity
- (2013) Anita K. Gandhi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN
- (2013) Anita K. Gandhi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
- (2013) G. Madhavi Sastry et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
- (2013) J. Kronke et al. SCIENCE
- Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy
- (2012) M. Chesi et al. BLOOD
- A Novel Approach to the Discovery of Small-Molecule Ligands of CDK2
- (2012) Mathew P. Martin et al. CHEMBIOCHEM
- Expansion of Effector Memory Regulatory T Cells Represents a Novel Prognostic Factor in Lower Risk Myelodysplastic Syndrome
- (2012) A. W. Mailloux et al. JOURNAL OF IMMUNOLOGY
- Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
- (2012) A Lopez-Girona et al. LEUKEMIA
- Behavioral characterization of cereblon forebrain-specific conditional null mice: A model for human non-syndromic intellectual disability
- (2011) Anjali M. Rajadhyaksha et al. BEHAVIOURAL BRAIN RESEARCH
- Functional modulation of AMP-activated protein kinase by cereblon
- (2011) Kwang Min Lee et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation
- (2011) Ruoning Wang et al. IMMUNITY
- Reversal of T-cell tolerance in myelodysplastic syndrome through lenalidomide immune modulation
- (2011) J M McDaniel et al. LEUKEMIA
- Protacs for Treatment of Cancer
- (2010) Kathleen M Sakamoto PEDIATRIC RESEARCH
- Identification of a Primary Target of Thalidomide Teratogenicity
- (2010) T. Ito et al. SCIENCE
- A spectrophotometric method for the determination of zinc, copper, and cobalt ions in metalloproteins using Zincon
- (2009) Crystal E. Säbel et al. ANALYTICAL BIOCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now